The role of the immune response in the pathogenesis of idiopathic pulmonary fibrosis (IPF) remains controversial.
It is now well established that there are different life-long lung function trajectories in the general population, and that some are associated with better or worse health outcomes.
The Global Burden of Disease Study 2017 identified that a country’s sociodemographic index was a key factor affecting mortality and loss of health from respiratory diseases.
COPD is the elephant in the room for many patients with CVDs.
Chronic Obstructive Pulmonary Disease (COPD) is the third cause of death worldwide. While tobacco smoking is a key risk factor, COPD also occurs in never-smokers (NS).
1 year after an acute COVID-19 episode, patients with either lung sequelae or long COVID show a stronger SARS-CoV-2-specific T-cell response than fully recovered individuals, suggesting persistent cell stimulation by residual viral reservoirs
Chief Editor James Chalmers interviews Alvar Agusti (Hospital Clinic, Barcelona, Spain)about the new Global Initiative for Chronic Obstructive Lung Disease (GOLD) report. Listen it here.
Los próximos 3, 4 y 5 de mayo tendrán lugar el VII Simposium Internacional de la EPOC y Tabaco y el XVII Simposium Internacional sobre prevención y tratamiento del tabaquismo.
«Chronic airway diseases such as asthma and chronic obstructive pulmonary disease are prevalent and complex conditions that often coexist in the same patient. To address this complexity in clinical practice, and to move forward toward personalized and precision…»
This issue of Archivos de Bronconeumología features an executive summary of the new 2023.
